Vaccine hesitancy is considered a major barrier to achieving herd immunity against COVID-19. While multiple alternative and synergistic approaches including heterologous vaccination, booster doses, and antiviral drugs have been developed, equitable vaccine uptake remains the foremost strategy to manage pandemic. Although none of the currently approved vaccines are live-attenuated, several reports of disease flares, waning protection, and acute-onset syndromes have emerged as short-term adverse events after vaccination. Hence, scientific literature falls short when discussing potential long-term effects in vulnerable cohorts. The COVAD-2 survey follows on from the baseline COVAD-1 survey with the aim to collect patient-reported data on the long-term safety and tolerability of COVID-19 vaccines in immune modulation. The e-survey has been extensively pilot-tested and validated with translations into multiple languages. Anticipated results will help improve vaccination efforts and reduce the imminent risks of COVID-19 infection, especially in understudied vulnerable groups.

COVAD survey 2 long-term outcomes: unmet need and protocol / Fazal, Z. Z.; Sen, P.; Joshi, M.; Ravichandran, N.; Lilleker, J. B.; Agarwal, V.; Kardes, S.; Kim, M.; Day, J.; Makol, A.; Milchert, M.; Gheita, T.; Salim, B.; Velikova, T.; Gracia-Ramos, A. E.; Parodis, I.; Nikiphorou, E.; Tan, A. L.; Chatterjee, T.; Cavagna, L.; Saavedra, M. A.; Shinjo, S. K.; Ziade, N.; Selva-O'Callaghan, A.; Nune, A.; Knitza, J.; Kuwana, M.; Gutierrez, C. -E. T.; Caballero-Uribe, C. V.; Dey, D.; Distler, O.; Chinoy, H.; Agarwal, V.; Aggarwal, R.; Gupta, L.; Barman, B.; Singh, Y. P.; Ranjan, R.; Jain, A.; Pandya, S. C.; Pilania, R. K.; Sharma, A.; M, M. M.; Gupta, V.; Kavadichanda, C. G.; Patro, P. S.; Ajmani, S.; Phatak, S.; Goswami, R. P.; Chowdhury, A. C.; Mathew, A. J.; Shenoy, P.; Asranna, A.; Bommakanti, K. T.; Shukla, A.; Pandey, A. K. R.; Gaur, P. S.; Mamadapur, M.; Ghodke, A.; Chandwar, K.; Jagtap, K.; Cansu, D. U.; Yildirim, R.; Patel, A.; Pauling, J. D.; Wincup, C.; Giannini, M.; Maurier, F.; Campagne, J.; Meyer, A.; Del Papa, N.; Sambataro, G.; Fabiola, A.; Govoni, M.; Parisi, S.; Bocci, E. B.; Sebastiani, G. D.; Fusaro, E.; Sebastiani, M.; Quartuccio, L.; Franceschini, F.; Sainaghi, P. P.; Orsolini, G.; De Angelis, R.; Danielli, M. G.; Venerito, V.; Grignaschi, S.; Giollo, A.; Traboco, L. S.; Shaharir, S. S.; Wibowo, S. A. K.; Tehozol, E. A. Z.; Serrano, J. R.; La Torre, I. G. -D.; Colunga-Pedraza, I. J.; Colunga-Pedraza, I. J.; Merayo-Chalico, J.; Loarce-Martos, J.; Prieto-Gonzalez, S.; Gil-Vila, A.; Aranega, R.; Hoff, L. S.; Nakashima, R.; Sato, S.; Kimura, N.; Kaneko, Y.; Tomaras, S.; Proft, F. N.; Holzer, M. -T.; Gromova, M. A.; Aharonov, O.; Nagy-Vincze, M.; Griger, Z.; Hmamouchi, I.; El bouchti, P. I.; Baba, Z.; Ima-Edomwonyi, U.; Dedeke, I.; Airenakho, E.; Madu, N. H.; Yerima, A.; Olaosebikan, H.; Chibuzo, O. C.; A, B.; Koussougbo, O. D.; Palalane, E.; Langguth, D.; Limaye, V.; Needham, M.; Srivastav, N.; Hudson, M.; Landon-Cardinal, O.; Zuleta, W. G. R.; Arbelaez, A.; Cajas, J.; Silva, J. A. P.; Fonseca, J. E.; Zimba, O.; Bohdana, D.; So, H.; Ugarte-Gil, M. F.; Chinchay, L.; Bernaola, J. P.; Pimentel, V.; Tanveer Hasan, A. T. M.; Saha, S.; Vaidya, B.; Fathi, H. M.; Mohammed, R. H. A.; Chen, Y. -M.; Harifi, G.; El Kibbi, L.; Halabi, H. M.; Akawatcharangura, P.; Katchamart, W.; Fuentes-Silva, Y.; Cabriza, K.; Losanto, J.; Colaman, N.; Cachafeiro-Vilar, A.; Bautista, G. G.; Ho, E. J. G.; Gonzalez, R. A.; Nunez, L. S.; M, C. V.; Baez, J. T.; Alonzo, H.; Pastelin, C. B. S.; Salinas, R. G.; Obiols, A. Q.; Chavez, N.; Ordonez, A. B.; Argueta, S.; Quijivix, D.; Llerena, G. A. R.; Sierra-Zorita, R.; Arrieta, D.; Hidalgo, E. R.; Saenz, R.; M, I. E.; Morales, R.; Calapaqui, W.; Quezada, I.; Arredondo, G.. - In: RHEUMATOLOGY INTERNATIONAL. - ISSN 1437-160X. - 42:12(2022), pp. 2151-2158. [10.1007/s00296-022-05157-6]

COVAD survey 2 long-term outcomes: unmet need and protocol

Sebastiani M.;
2022

Abstract

Vaccine hesitancy is considered a major barrier to achieving herd immunity against COVID-19. While multiple alternative and synergistic approaches including heterologous vaccination, booster doses, and antiviral drugs have been developed, equitable vaccine uptake remains the foremost strategy to manage pandemic. Although none of the currently approved vaccines are live-attenuated, several reports of disease flares, waning protection, and acute-onset syndromes have emerged as short-term adverse events after vaccination. Hence, scientific literature falls short when discussing potential long-term effects in vulnerable cohorts. The COVAD-2 survey follows on from the baseline COVAD-1 survey with the aim to collect patient-reported data on the long-term safety and tolerability of COVID-19 vaccines in immune modulation. The e-survey has been extensively pilot-tested and validated with translations into multiple languages. Anticipated results will help improve vaccination efforts and reduce the imminent risks of COVID-19 infection, especially in understudied vulnerable groups.
2022
42
12
2151
2158
COVAD survey 2 long-term outcomes: unmet need and protocol / Fazal, Z. Z.; Sen, P.; Joshi, M.; Ravichandran, N.; Lilleker, J. B.; Agarwal, V.; Kardes, S.; Kim, M.; Day, J.; Makol, A.; Milchert, M.; Gheita, T.; Salim, B.; Velikova, T.; Gracia-Ramos, A. E.; Parodis, I.; Nikiphorou, E.; Tan, A. L.; Chatterjee, T.; Cavagna, L.; Saavedra, M. A.; Shinjo, S. K.; Ziade, N.; Selva-O'Callaghan, A.; Nune, A.; Knitza, J.; Kuwana, M.; Gutierrez, C. -E. T.; Caballero-Uribe, C. V.; Dey, D.; Distler, O.; Chinoy, H.; Agarwal, V.; Aggarwal, R.; Gupta, L.; Barman, B.; Singh, Y. P.; Ranjan, R.; Jain, A.; Pandya, S. C.; Pilania, R. K.; Sharma, A.; M, M. M.; Gupta, V.; Kavadichanda, C. G.; Patro, P. S.; Ajmani, S.; Phatak, S.; Goswami, R. P.; Chowdhury, A. C.; Mathew, A. J.; Shenoy, P.; Asranna, A.; Bommakanti, K. T.; Shukla, A.; Pandey, A. K. R.; Gaur, P. S.; Mamadapur, M.; Ghodke, A.; Chandwar, K.; Jagtap, K.; Cansu, D. U.; Yildirim, R.; Patel, A.; Pauling, J. D.; Wincup, C.; Giannini, M.; Maurier, F.; Campagne, J.; Meyer, A.; Del Papa, N.; Sambataro, G.; Fabiola, A.; Govoni, M.; Parisi, S.; Bocci, E. B.; Sebastiani, G. D.; Fusaro, E.; Sebastiani, M.; Quartuccio, L.; Franceschini, F.; Sainaghi, P. P.; Orsolini, G.; De Angelis, R.; Danielli, M. G.; Venerito, V.; Grignaschi, S.; Giollo, A.; Traboco, L. S.; Shaharir, S. S.; Wibowo, S. A. K.; Tehozol, E. A. Z.; Serrano, J. R.; La Torre, I. G. -D.; Colunga-Pedraza, I. J.; Colunga-Pedraza, I. J.; Merayo-Chalico, J.; Loarce-Martos, J.; Prieto-Gonzalez, S.; Gil-Vila, A.; Aranega, R.; Hoff, L. S.; Nakashima, R.; Sato, S.; Kimura, N.; Kaneko, Y.; Tomaras, S.; Proft, F. N.; Holzer, M. -T.; Gromova, M. A.; Aharonov, O.; Nagy-Vincze, M.; Griger, Z.; Hmamouchi, I.; El bouchti, P. I.; Baba, Z.; Ima-Edomwonyi, U.; Dedeke, I.; Airenakho, E.; Madu, N. H.; Yerima, A.; Olaosebikan, H.; Chibuzo, O. C.; A, B.; Koussougbo, O. D.; Palalane, E.; Langguth, D.; Limaye, V.; Needham, M.; Srivastav, N.; Hudson, M.; Landon-Cardinal, O.; Zuleta, W. G. R.; Arbelaez, A.; Cajas, J.; Silva, J. A. P.; Fonseca, J. E.; Zimba, O.; Bohdana, D.; So, H.; Ugarte-Gil, M. F.; Chinchay, L.; Bernaola, J. P.; Pimentel, V.; Tanveer Hasan, A. T. M.; Saha, S.; Vaidya, B.; Fathi, H. M.; Mohammed, R. H. A.; Chen, Y. -M.; Harifi, G.; El Kibbi, L.; Halabi, H. M.; Akawatcharangura, P.; Katchamart, W.; Fuentes-Silva, Y.; Cabriza, K.; Losanto, J.; Colaman, N.; Cachafeiro-Vilar, A.; Bautista, G. G.; Ho, E. J. G.; Gonzalez, R. A.; Nunez, L. S.; M, C. V.; Baez, J. T.; Alonzo, H.; Pastelin, C. B. S.; Salinas, R. G.; Obiols, A. Q.; Chavez, N.; Ordonez, A. B.; Argueta, S.; Quijivix, D.; Llerena, G. A. R.; Sierra-Zorita, R.; Arrieta, D.; Hidalgo, E. R.; Saenz, R.; M, I. E.; Morales, R.; Calapaqui, W.; Quezada, I.; Arredondo, G.. - In: RHEUMATOLOGY INTERNATIONAL. - ISSN 1437-160X. - 42:12(2022), pp. 2151-2158. [10.1007/s00296-022-05157-6]
Fazal, Z. Z.; Sen, P.; Joshi, M.; Ravichandran, N.; Lilleker, J. B.; Agarwal, V.; Kardes, S.; Kim, M.; Day, J.; Makol, A.; Milchert, M.; Gheita, T.; S...espandi
File in questo prodotto:
File Dimensione Formato  
s00296-022-05157-6.pdf

Open access

Tipologia: Versione pubblicata dall'editore
Dimensione 634.01 kB
Formato Adobe PDF
634.01 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1292564
Citazioni
  • ???jsp.display-item.citation.pmc??? 7
  • Scopus 32
  • ???jsp.display-item.citation.isi??? 35
social impact